Literature DB >> 26443992

Super enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapy.

Hisataka Kobayashi1, Peter L Choyke.   

Abstract

To date, the delivery of nano-sized therapeutic agents to cancers largely relies on enhanced permeability and retention (EPR) effects that are caused by the leaky nature of cancer vasculature. However, nano-sized agents delivered in this way have demonstrated limited success in oncology due to the relatively small magnitude of the EPR effect. For achieving superior delivery of nano-sized agents, super-enhanced permeability and retention (SUPR) effects are needed. Near infrared photo-immunotherapy (NIR-PIT) is a recently reported therapy that treats tumors with light therapy and subsequently causes an increase in nano-drug delivery up to 24-fold compared with untreated tumors in which only the EPR effect is present. SUPR effects could enhance delivery into tumor beds of a wide variety of nano-sized agents including particles, antibodies, and protein binding small molecular agents. Therefore, taking advantage of the SUPR effects after NIR-PIT may be a promising avenue to utilize a wide variety of nano-drugs in a highly effective manner.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26443992      PMCID: PMC4824660          DOI: 10.1039/c5nr05552k

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  18 in total

Review 1.  Antibody-drug conjugates: current status and future directions.

Authors:  Heidi L Perez; Pina M Cardarelli; Shrikant Deshpande; Sanjeev Gangwar; Gretchen M Schroeder; Gregory D Vite; Robert M Borzilleri
Journal:  Drug Discov Today       Date:  2013-11-15       Impact factor: 7.851

2.  Real-time monitoring of hemodynamic changes in tumor vessels during photoimmunotherapy using optical coherence tomography.

Authors:  Chia-Pin Liang; Takahito Nakajima; Rira Watanabe; Kazuhide Sato; Peter L Choyke; Yu Chen; Hisataka Kobayashi
Journal:  J Biomed Opt       Date:  2014-09       Impact factor: 3.170

3.  Photoimmunotherapy of hepatocellular carcinoma-targeting Glypican-3 combined with nanosized albumin-bound paclitaxel.

Authors:  Hirofumi Hanaoka; Takahito Nakajima; Kazuhide Sato; Rira Watanabe; Yen Phung; Wei Gao; Toshiko Harada; Insook Kim; Chang H Paik; Peter L Choyke; Mitchell Ho; Hisataka Kobayashi
Journal:  Nanomedicine (Lond)       Date:  2015       Impact factor: 5.307

Review 4.  Antibody-drug conjugates: an emerging concept in cancer therapy.

Authors:  Ravi V J Chari; Michael L Miller; Wayne C Widdison
Journal:  Angew Chem Int Ed Engl       Date:  2014-02-20       Impact factor: 15.336

Review 5.  The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect.

Authors:  Hiroshi Maeda
Journal:  Cancer Sci       Date:  2013-04-22       Impact factor: 6.716

Review 6.  Imaging of angiogenesis: from microscope to clinic.

Authors:  Donald M McDonald; Peter L Choyke
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

7.  Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors.

Authors:  Kohei Sano; Takahito Nakajima; Peter L Choyke; Hisataka Kobayashi
Journal:  ACS Nano       Date:  2012-12-18       Impact factor: 15.881

8.  Dynamic fluorescent imaging with indocyanine green for monitoring the therapeutic effects of photoimmunotherapy.

Authors:  Towhid Ali; Takahito Nakajima; Kohei Sano; Kazuhide Sato; Peter L Choyke; Hisataka Kobayashi
Journal:  Contrast Media Mol Imaging       Date:  2014 Jul-Aug       Impact factor: 3.161

9.  Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling.

Authors:  Mitsunobu R Kano; Younsoo Bae; Caname Iwata; Yasuyuki Morishita; Masakazu Yashiro; Masako Oka; Tomoko Fujii; Akiyoshi Komuro; Kunihiko Kiyono; Michio Kaminishi; Kosei Hirakawa; Yasuyoshi Ouchi; Nobuhiro Nishiyama; Kazunori Kataoka; Kohei Miyazono
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-16       Impact factor: 12.779

10.  Nano delivers big: designing molecular missiles for cancer therapeutics.

Authors:  Sachin Patel; Ashwin A Bhirde; James F Rusling; Xiaoyuan Chen; J Silvio Gutkind; Vyomesh Patel
Journal:  Pharmaceutics       Date:  2011       Impact factor: 6.321

View more
  27 in total

1.  Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer.

Authors:  Kimihiro Ito; Makoto Mitsunaga; Takashi Nishimura; Masayuki Saruta; Takeo Iwamoto; Hisataka Kobayashi; Hisao Tajiri
Journal:  Bioconjug Chem       Date:  2017-04-26       Impact factor: 4.774

2.  Looking into the clinical application of CD47-targeted near-infrared photoimmunotherapy for human bladder cancer treatment.

Authors:  Jayoung Kim
Journal:  Transl Androl Urol       Date:  2019-07

Review 3.  Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.

Authors:  Emily B Ehlerding; Piotr Grodzinski; Weibo Cai; Christina H Liu
Journal:  ACS Nano       Date:  2018-03-01       Impact factor: 15.881

4.  Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes.

Authors:  Shun Kishimoto; Nobu Oshima; Kazutoshi Yamamoto; Jeeva Munasinghe; Jan Henrik Ardenkjaer-Larsen; James B Mitchell; Peter L Choyke; Murali C Krishna
Journal:  Free Radic Biol Med       Date:  2017-12-29       Impact factor: 7.376

5.  3D mesoscopic fluorescence tomography for imaging micro-distribution of antibody-photon absorber conjugates during near infrared photoimmunotherapy in vivo.

Authors:  Qinggong Tang; Tadanobu Nagaya; Yi Liu; Hannah Horng; Jonathan Lin; Kazuhide Sato; Hisataka Kobayashi; Yu Chen
Journal:  J Control Release       Date:  2018-04-16       Impact factor: 9.776

6.  Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towards Conquering Desmoplasia?

Authors:  Girgis Obaid; Shazia Bano; Srivalleesha Mallidi; Mans Broekgaarden; Jerrin Kuriakose; Zachary Silber; Anne-Laure Bulin; Yucheng Wang; Zhiming Mai; Wendong Jin; Diane Simeone; Tayyaba Hasan
Journal:  Nano Lett       Date:  2019-10-04       Impact factor: 11.189

Review 7.  Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?

Authors:  Yuko Nakamura; Ai Mochida; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2016-09-02       Impact factor: 4.774

8.  Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy.

Authors:  Colin T Huang; Xin Guo; Cyril Bařinka; Shawn E Lupold; Martin G Pomper; Kathleen Gabrielson; Venu Raman; Dmitri Artemov; Sudath Hapuarachchige
Journal:  Mol Pharm       Date:  2020-08-17       Impact factor: 4.939

Review 9.  Photodynamic Therapy and the Biophysics of the Tumor Microenvironment.

Authors:  Aaron J Sorrin; Mustafa Kemal Ruhi; Nathaniel A Ferlic; Vida Karimnia; William J Polacheck; Jonathan P Celli; Huang-Chiao Huang; Imran Rizvi
Journal:  Photochem Photobiol       Date:  2020-03-05       Impact factor: 3.421

10.  Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.

Authors:  Kangyu Zheng; Xiangmei Liu; Junfeng Ban; Zeju Huang; Jiaying Huang; Xin Huang; Haosen Luo; Zhicong Chen; Qingchun Xie; Yanzhong Chen; Zhufen Lu
Journal:  Drug Des Devel Ther       Date:  2021-06-17       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.